Amino Acid ·Strong evidence ·Reviewed May 2026
Precursor to nitric oxide, supporting blood flow and cardiovascular health.
The bottom line
Evidence rating strong. Most-documented uses: blood flow, cardiovascular health, exercise performance. 19 sources indexed (2011–2025), with 18 interaction records on file.
Core mechanism
Converted to nitric oxide (NO) by nitric oxide synthase (NOS). NO relaxes vascular smooth muscle, improving blood flow. Also supports growth hormone release and wound healing.16,13
Empty stomach preferred for exercise; with food to reduce GI6,2
Dosing protocol
Citrulline outperforms arginine for sustained NO support because of first-pass arginase metabolism.6
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes L-Arginine HCl.
Assumes 3-6 g/day. Vendor basis: BulkSupplements powder, NOW Sports/iHerb, Vitacost, and Amazon marketplace; powder is much cheaper than capsules. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Whole foods provide arginine within protein and alongside other amino acids.
Dose: 3-6 g daily16
Timing: Split doses, away from heavy meals
Clinical dose evidence: PMID 27660594.
What to test, the optimal window inside the conventional range, and how long a response takes.
L-arginine (3 to 9 g per day) raises plasma arginine acutely. Effect on NO production is limited by ADMA (asymmetric dimethylarginine) competition.16,1
L-citrulline raises plasma arginine more reliably than L-arginine itself because of first-pass arginase metabolism. Track ADMA if cardiovascular focus.
L-Arginine is expected to modestly lower systolic blood pressure, with effects that are generally small, dose-dependent, and most apparent when baseline pressure is elevated.12,6
Sit quietly for 5 minutes before measuring, use the same arm and time of day, and avoid caffeine, nicotine, and exercise beforehand. Average 2 to 3 readings and compare against a matched baseline.
Where this appears in the symptom-to-supplement map, ranked by relevance.
L-arginine is the substrate for nitric oxide synthesis and may support endothelial function and vasodilation in some populations.16,13
Oral bioavailability is limited by first-pass metabolism; use caution after recent heart attack and in herpes-prone individuals.
L-arginine is a nitric oxide precursor that promotes vasodilation, which may improve peripheral blood flow during cold-induced vasospasm.1,2
Results are mixed and short-lived; L-citrulline may raise arginine more reliably for some people.
Direct NO precursor, though first-pass metabolism limits efficiency compared with citrulline.3
Lower bioavailability than citrulline at equivalent doses.
Arginine is the direct substrate for nitric oxide synthesis, supporting vasodilation when endothelial function is impaired.13,16
First-pass metabolism limits the rise in blood arginine, so citrulline is often the more effective route.
L-arginine is a nitric oxide precursor that has been trialed for interstitial cystitis symptom relief, with inconsistent and at best modest results.1,2
Evidence is weak and mixed; discuss with your urologist before adding, and treat it as supportive only for this medical condition.
Arginine is the direct precursor for nitric oxide synthesis and vasodilation in narrowed peripheral arteries.
Trial results are inconsistent and one long-term study showed no benefit; clear it with your clinician, especially after a heart attack.
Arginine supports nitric oxide-mediated vasodilation; modest effect on peripheral circulation.13,16
Citrulline outperforms arginine for sustained NO support.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
L-Arginine is a direct nitric oxide precursor, but oral doses undergo extensive first-pass metabolism that blunts the rise in plasma arginine, so its independent ergogenic effect is uncertain and L-Citrulline is generally the more reliable pathway.13,16
L-Arginine is a substrate for nitric oxide synthase and supports vasodilation, and small combination trials suggest possible benefit for female arousal. Evidence is mixed and largely from multi-ingredient products, so any effect is uncertain.16,13
L-Arginine is a substrate for nitric oxide and proline (and therefore collagen) and may support immune function and local perfusion during the proliferative phase of healing. Supplemental arginine has shown benefit mainly in surgical and pressure-injury settings, so its value in otherwise well-nourished people is less certain.16,13
Arginine and lysine compete for cellular uptake; high-dose arginine can reduce lysine's effect on HSV outbreak prevention.
Recommendation: Separate by 2 hours and avoid high-dose arginine during active HSV outbreaks. Reduce dietary arginine sources (nuts, chocolate) when using lysine for HSV.
Citrulline is converted to arginine in the kidney, raising plasma arginine higher and longer than oral arginine alone. Combined use provides additive NO support.
Recommendation: Use citrulline as the primary NO precursor; if combining with arginine, take citrulline 1 to 2 hours before arginine or together pre-workout.
Pine bark extract (Pycnogenol) combined with L-arginine improved erectile function and endothelial nitric oxide signaling in controlled clinical trials more than expected from either alone.
Recommendation: A reasonable evidence-based pairing for vascular and erectile support. People on blood-pressure-lowering medication should monitor for additive hypotension.
The pair approaches sexual function from two angles, with Maca acting on libido and sexual desire while L-Arginine supports the nitric oxide pathway involved in blood flow and erectile response.
Recommendation: May be combined for libido and erectile support. Maca is taken daily over weeks; L-Arginine is often dosed at 1.5 to 5g per day. Use caution with antihypertensives or nitrates given L-Arginine vasodilation.
These two are frequently stacked in test booster plus pump formulas on the assumption that they are synergistic, but in testicular tissue they act in opposite directions on testosterone production. In testicular incubation models, D-Aspartic Acid raised testosterone output while nitric oxide from L-Arginine lowered it, so the net hormonal effect can be antagonistic rather than additive. The interaction is at the steroidogenic step (an opposing physiological effect mediated by nitric oxide), not a safety hazard. The evidence is animal and tissue-level, and human confirmation is lacking, so this is best framed as a likely efficacy conflict rather than a proven clinical event.
Recommendation: If the goal of D-Aspartic Acid use is testosterone or LH support, do not assume L-Arginine adds to it, and consider that high-dose L-Arginine (commonly 3 to 6 g) may partially offset it. If you take both (for example D-Aspartic Acid for the HPG axis and L-Arginine for blood flow), separate them by several hours and keep D-Aspartic Acid on an empty stomach in the morning. There is no toxicity concern with co-use; the issue is potential loss of the desired hormonal effect. Track response with bloodwork if it matters to you.
L-arginine is a nitric oxide precursor, and sildenafil enhances NO/cGMP signaling by inhibiting PDE5. Combined use can cause additive vasodilation and significant hypotension.
Recommendation: Use caution when combining. Start L-arginine at low doses. Monitor for headache, dizziness, flushing, and low blood pressure. Do NOT combine with nitrates.
Same mechanism as sildenafil + L-arginine. Tadalafil has a 36-hour half-life, making the interaction window much longer than sildenafil.
Recommendation: Use caution. Tadalafil's long duration means the vasodilatory interaction persists for 1-2 days. Start L-arginine at low doses.
L-Arginine is the substrate for endothelial nitric oxide synthase, and oral supplementation produces modest blood pressure reductions (about 5 mm Hg systolic in a meta-analysis of double-blind trials). ACE inhibitors like lisinopril also raise nitric oxide bioavailability through bradykinin. The effects are additive and generally beneficial.
Recommendation: L-Arginine 3-6 g/day is a reasonable add-on; monitor home blood pressure after starting and tell your prescriber so your lisinopril dose can be reviewed. Avoid combination with sildenafil or tadalafil without medical guidance.
L-Arginine is a nitric oxide precursor that lowers blood pressure on its own. Stacked with metoprolol's beta1 blockade, the combined fall in blood pressure can produce symptomatic hypotension, dizziness, or lightheadedness, especially when standing. Patients who are already well-controlled on metoprolol are the most likely to overshoot.
Recommendation: If you take metoprolol for blood pressure, check your readings before and after starting L-arginine, and start with lower doses (e.g., 1-3 g/day). Stop or reduce the dose if you develop dizziness, fatigue, or readings below your usual range, and tell your prescriber.
L-Arginine modestly lowers blood pressure through nitric oxide-mediated vasodilation. Stacked with atenolol's beta1 blockade, the combined drop can produce symptomatic hypotension, especially in older adults or those already well-controlled.
Recommendation: If you take atenolol, start L-arginine at lower doses (1-3 g/day) and monitor your blood pressure for 1-2 weeks. Reduce or stop if you develop dizziness, fatigue, or readings below your usual range.
Nitroglycerin and L-arginine both increase nitric-oxide-mediated vasodilation. Using them together can add to blood pressure lowering, headaches, flushing, dizziness, or fainting, especially in older adults, dehydration, nitrate-naive patients, or people already taking antihypertensives. The risk is pharmacodynamic, so simply spacing doses may not fully prevent it.
Recommendation: Do not start high-dose L-arginine while using nitroglycerin without prescriber input. If your clinician allows the combination, start with a low L-arginine dose, monitor blood pressure, sit or lie down after nitroglycerin, and stop L-arginine if you develop lightheadedness or unusually low readings.
Isosorbide mononitrate and L-arginine both increase nitric-oxide-mediated vasodilation. In a human crossover study, L-arginine enhanced the blood pressure and pulse-wave effects of isosorbide mononitrate in some older hypertensive patients. This can be useful in supervised care but can also cause excessive dizziness, headache, or fainting when added without monitoring.
Recommendation: Do not add high-dose L-arginine to isosorbide mononitrate unless your prescriber is aware. If combined, check sitting and standing blood pressure during the first week, rise slowly, and stop the supplement if you develop faintness or unusually low readings.
Numbered references. Citations throughout the page link here.
Makama M, McDougall ARA, Cao J et al.. L-Arginine and L-Citrulline for Prevention and Treatment of Pre-Eclampsia: A Systematic Review and Meta-Analysis. BJOG : an international journal of obstetrics and gynaecology. 2025
Nejati M, Dehghan P, Safari S et al.. The influence of arginine supplementation on IGF-1: A systematic review and meta-analysis. Clinical nutrition ESPEN. 2023
Tian Y, Zhou Q, Li W et al.. Efficacy of L-arginine and Pycnogenol ® in the treatment of male erectile dysfunction: a systematic review and meta-analysis. Frontiers in endocrinology. 2023
Cheshmeh S, Hojati N, Mohammadi A et al.. The use of oral and enteral tube-fed arginine supplementation in pressure injury care: A systematic review and meta-analysis. Nursing open. 2022
Stefanetti RJ, Ng YS, Errington L et al.. l-Arginine in Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes: A Systematic Review. Neurology. 2022
In 11 RCTs, L-arginine supplementation significantly increased VO2 max compared to control. L-arginine in pure form significantly increased VO2 max (WMD 0.11 L/min, I2=0.0%). No significant heterogeneity was observed.
Arginine showed positive impact on sport performance through NO-mediated mechanisms, but results were controversial and not uniformly significant.
In 12 RCTs, L-arginine supplementation significantly reduced serum triglycerides (WMD -7.04 mg/dl, p<0.001) but did not significantly change total cholesterol, LDL, or HDL levels.
Evidence supports L-arginine supplementation for reducing blood pressure in hypertensive adults and reducing hospital-acquired infections.
Oral L-arginine supplementation significantly lowered systolic BP by 5.39 mmHg and diastolic BP by 2.66 mmHg compared to placebo across 11 RCTs.
SBP reduced 5.39 mmHg, DBP reduced 2.66 mmHg via nitric oxide pathway
L-arginine is the substrate for nitric oxide synthase (NOS); NO production is essential for blood pressure regulation and immune function.
Arginine supplementation contributed to improved pressure ulcer healing in older adults, with international guidelines recommending arginine-enriched nutrition for stage 2+ pressure injuries.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack